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SUMMARY 
Background and Objectives: Blood incompatibility arises from individual and ethnic differences in 
red blood cell (RBC) antigen profiles. This underlines the importance of documenting RBC antigen 
variability in various ethnic groups. Central Asia is an area with a long and complex migratory history. 
The purpose of this article is to describe key antigen frequencies of Afghan ethnic groups in the 
Hindu-Kush region of Afghanistan as a basis for improving blood transfusion practices in that area.  
Material and Methods: The key ABO, Rh and Kell antigens were investigated in five Afghan 
populations. In order to depict accurately the blood group gene diversity in the area, DNA from eight 
additional Pakistani populations were included, and the entire sample set screened using two multiplex 
PCRs sensitive for 17 alleles in 10 blood group genetic systems (MNS, Kell, Duffy, Kidd, Cartwright, 
Dombrock, Indian, Colton, Diego and Landsteiner-Wiener).  
Results: Phenotype and allele frequencies fell within the ranges observed in Western European and 
East Asian populations. Occurrence of DI*01, IN*01, LW*07, and FY*02N.01 and prevalence of 
ABO*B.01 were consistent with migratory history as well as with putative environmental adaptation in 
the subtropical environment Hindu-Kush region. 
Conclusion: These findings expand current knowledge about key antigen frequencies. Regarding 
occurrence of viral markers, further blood transfusion in the region requires rigorous typing. 
 
Key words: Hindu-Kush populations, multiplex genotyping, blood group antigens 
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INTRODUCTION 
Transfusion institutions strive to provide blood products that are microbiologically safe and 
compatible with recipient blood characteristics. Achieving this goal requires stringent pre-transfusion 
screening at two levels. The first level involves blood cell antigens. To date, the International Society 
Blood Transfusion (ISBT) has recorded a total of 339 blood group specificities including 297 in 33 
systems (Reid et al. 2012). Since the ABO and Rh antigens can be immunologically significant due to 
the presence of natural ABO antibodies and strong immunogenicity of the RHD antigen, systematic 
ABO-RhD typing is necessary. The second level of pre-transfusion screening involves identification 
of Rh-Kell antigenic profiles and, to a lesser extent, Duffy, Kidd and Ss phenotype. Screening for the 
latter phenotypes is necessary depending on the patient, pathology and risk of alloimmunization.  
In addition to ensuring transfusion safety, awareness of antigen frequency in a given 
population is crucial to defining product requirements and minimum stock levels. Given the high 
variability of red cell antigens, transfusion institutes must determine antigen frequencies in the 
population that they serve. Such determination is especially important in population settings like 
Afghanistan (Witzel 1999). In Kabul, the Central Blood Bank (BCS, Banque Centrale du Sang) was 
established in the 1980s, but political unrest, lack of funding and policy matters forced closure 
between 1992 and 1995. Since 1995, the BCS has been working to maintain a sound basis for a self-
sufficient blood transfusion system under the auspices of four government ministries: Health, Defense, 
National Security, and Home Affairs. 
The Etablissement Français du Sang Alpes-Méditerranée (EFS-AM) has been deeply involved 
in the rehabilitation of the BCS in Kabul. In 1999, an initial study conducted in collaboration with the 
EFS-AM presented the serological profile and blood characteristics of the population living in the 
Afghan capital (Dupire et al. 1999). In 2008, the EFS-AM with the support of the Agence Nationale de 
la Recherche implemented the AFGHAPOP program in a larger sample of the Afghan population in 
surrounding areas. The twofold goal of AFGHAPOP was to describe genetic diversity based on 
anthropological genetic markers and improve the safety of blood transfusion in Afghanistan. 
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The present report describes results obtained in a cohort of blood donors originating from the 
main Afghan communities studied within the framework of the AFGHANPOP program. The primary 
study objective was to define the frequency of key antigens (ABO, Rh, Kell) and prevalence of other 
blood group genes for blood transfusion. The secondary objective was to gain better insight into the 
distribution of red cell antigens in human populations and highlight the correlated anthropological and 
environmental factors. 
 
MATERIAL AND METHODS 
Sample collection 
This study was approved by the Afghan authorities and CNRS ethics committee. Blood 
collection was performed after obtaining informed consent in 5 Afghan populations living in the 
mountainous Hindu-Kush region: Hazara, Pashto, Uzbek, Tajik and Turkmen. To allow accurate 
interpretation of the Afghan dataset in the geographical and anthropological context, 168 additional 
DNA samples from 8 Pakistani populations (Hazara, Kalash, Makrani, Balochi, Brahui, Burusho, 
Pathan and Sindhi) were obtained from the Centre d'Etude du Polymorphisme Humain (HGDP-CEPH) 
(Cann et al. 2002).  
 
Surface antigen typing 
A total of 507 blood samples were selected for red cell antigen typing of the ABO, Rh, and 
Kell blood group systems. Typing was carried out in Kabul with Diagast (France) reagents anti-A 
(Clone 9113D10), -B (Clone 9621A8), -AB (Clones 9113D10 + 152D12), and -D (Clones P3x61 + 
P3x21223B10 + P3x290 + P3x35); and Eurobio (France) reagents anti-C (Clones MS273), -c (Clone 
MS35), -E (Clones MS12 + MS260), -e (MS62 + MS69) and –K (Clone AEK4).  
 
Blood group genotyping by two Singleplex PCR 
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Genomic DNA was extracted from whole blood samples using the QIAamp DNA Blood Mini 
Kit (Qiagen) and stored at -20°C (-4°F). Genotyping of both Afghan and Pakistani samples was 
performed using two multiplex PCRs at the EFS-AM in Marseilles, France with focus on 17 
polymorphisms coding for MNS, Kell, Duffy, Kidd, Cartwright, Dombrock, Indian, Colton, Diego and 
Landsteiner-Wiener red cell antigens of transfusion and anthropological interest. The first one was 
designed for simultaneous detection of 11 SNPs of the GYPB (MNS), KEL (KEL), FY (FY), SLC14A1 
(JK), ACHE (YT), DO (DO), AQP1 (CO) genes whose red cell antigens are strongly implicated in 
transfusion reactions (Daniels et al. 2004; Di Cristofaro et al. 2010).  
The second multiplex PCR was developed to screen 10 polymorphisms defining 15 alleles of 
anthropological interest: KEL*02.06, FY*01/FY*02, FY*02M.01, FY*02N.01, DI*01/DI*02, 
DO*01/DO*02, DO*02.-04, DO*01.-05, LW*05/LW*07 and IN*01/IN*02 (Table1). Some of these 
markers are redundant with the first multiplex PCR devoted to transfusion purposes (Di Cristofaro et 
al. 2010). It was performed on 250 ng of genomic DNA in a final volume of 25 µl containing 0.05 unit 
of TaqDNA-polymerase and 2X of the provided PCR buffer (Invitrogen, Cergy Pontoise, France), 3.4 
mmol/L MgCl2, 0.2 mmol/L of each dNTP, and a suitable concentration of each primer (see table 1 
for final concentration). Amplification was performed under stringent conditions: 96°C for 5 minutes 
for 1 cycle; 94°C for 30 seconds, 64°C for 30 seconds, 72°C for 1 minute for 30 cycles, followed by 
one 10-minute-long cycle at 72°C. PCR amplicon purification were described elsewhere (Di 
Cristofaro et al. 2010). Probe primer extensions for the SNaPshot reaction are presented in Table 1. 
Primer extension reactions were segregated by capillary electrophoresis on an automated fluorescence-
based ABI PRISM 3130 XL genetic analyzer according to manufacturer’s protocol. 
In order to check accuracy and reproducibility of the multiplex SNaPshot assay presented 
here, the genotypes not included in the first multiplex (Di Cristofaro et al. 2010) were validated with 
known phenotypes obtained by serology and sequencing. For the crossmatch of the results using 
serology, only the anti-Fya (Clone DG-FYA-02, Diagast, France) and anti-Fyb (polyclonal, Diagast, 
France) antibodies were available. In addition, the validation was enhanced using 41 representative 
homozygotes and heterozygotes from our collection to act as control samples by direct sequencing. 
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However, six genotypes could not be checked because of their scarcity: heterozygote for DO*02.-04 
or DO*01.-05; homozygote for the total absence of DO*02.-04 or DO*01.-05; IN*01/01; and 
LW*07/07. 
 
Statistical analysis 
Red cell antigen frequencies were calculated by direct counting. ABO allele frequencies were 
estimated from the ABO phenotypes using Bernstein’s method that calls for direct counting in the case 
of genotypes with recessive alleles (Bernstein 1925). By default we labeled the traditional ABO*A.01, 
ABO*B.01 and ABO*O.01.01 alleles as the ones coding for the observe phenotypes. RH haplotype 
frequencies were estimated from the RH phenotypes using the Expectation-Maximization (EM) 
algorithm in the GENE[RATE] package (Nunes 2006). Assuming the Hardy-Weinberg equilibrium, 
this procedure enables to estimate the maximum-likelihood haplotype frequencies from multi-locus 
genotype data and considers all possibilities of genotypic ambiguities, that is when several genotypes 
can lead to the same phenotype (Dempster et al. 1977). The EM algorithm was done with 1000 
iterations of all possible haplotype combinations. 
Population comparison was performed between data obtained using Bernstein's method and 
the EM algorithm and previous ABO, Rh and Kell data including Western Europeans, Sub-Saharans, 
983 West Asians, circa 43,000 South Asians and an undefined number of East Asians described in the 
literature (Cavalli-Sforza et al. 1994; Nanu and Thapliyal 1997; Dupire et al. 1999; Asadov et al. 
2003; Periyavan et al. 2010; Thakral et al. 2010; Keramati et al. 2011; Radzhabov et al. 2011; Reid et 
al. 2012). 
 
RESULTS 
Data obtained by serological ABO, Rh and Kell antigen testing observed in the Afghan 
samples are given in Table 2, and the inferred allele frequencies in Table 3. The last five columns of 
Table 3 present the allele frequencies observed in the main Western European, Sub-Saharan, and 
Asian populations. A striking feature of the ABO system in the Afghan populations studied here was 
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the predominance of the phenotype B (range: 25-32%) and frequency of the ABO*B.01 allele (range, 
21-25%). Higher AB phenotype frequencies were observed in the Uzbek, Tajik, Turkmen and Pashto 
ethnic groups (13-15%) than in the Hazara group (4%). The O phenotype was found in 26 to 35% of 
the individuals serotyped and the estimated ABO*O.01.01 allele frequency ranged between 50 and 
60%. 
Regarding Rh phenotypes, the frequency of D- ranged from 6% in the Pashto, and Tajik 
groups to 16% in the Hazara group. Three D- phenotypes were observed: D-C+E-c+e+ in two Hazaras 
and one Turkmen, D-C-E+c+e+ in one Tajik, and the ubiquitous D-C-E-c+e+ that ranged from 6% 
(n=5) in the Pashto to 13% (n= 10) in the Hazara. A total of four D+ phenotypes were encountered in 
the five Afghan populations. The most frequent D+ phenotype was D+C+E-c-e+ (range, 31-37%) 
followed by D+C+E-c+e+ (range, 22-33%), D+C+E+c+e+ (range 16-19%) and D+C-E+c+e+ (range, 
6% to 14%).  
Based on the estimates inferred from the RH phenotypes using the EM algorithm of 
GENE[RATE] (Dempster et al. 1977; Nunes 2006), the three most prevalent haplotypes in the five 
Afghan populations were DCe, dce and DcE, accounting for 51-54%, 24-29% and 13-19% 
respectively. The Dce haplotype ranged from 3 to 4% in the Pashto, Tajik and Uzbek groups and the 
dCe haplotype ranged from 3 to 5% in the Hazara and Turkmen groups. The DCE haplotype, which is 
characteristic of Asian populations (1-3%), was observed only in the Pashto (1%) and Tajik (2%) 
groups. Only the Tadjiik group carried the European-specific dcE haplotype (1%). The dCE haplotype 
was not detected in any of the five Afghan populations.  
With regard to the Kell system, the K antigen was detected in all five ethnic groups. Its 
frequency ranged from one case (1%) each in the Tajik and Turkmen groups up to seven cases in the 
Uzbek group (6%).  
Table 4 shows the frequencies of 15 biallelic polymorphisms successfully amplified in 5 
Afghan and 8 Pakistani populations. In the samples under study, the DO*02.-04 and DO*01.-05 
alleles were ubiquitously found, and conversely the GYPB*03N.03 and GYPB*03N.02 alleles were not 
encountered. The two latter were not included in Table 4. Seven alleles were sporadically detected 
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with a frequency of less than 4%: KEL*01.1, KEL*02.06, FY*02M.01, DI*01, IN*01, LW*07 and 
CO*02. KEL*02.06 coding for the Jsa
 
antigen was observed in one heterozygous Tajik, and IN*01 
responsible for the Ina antigen was detected in one heterozygous Tajik and one heterozygous Burusho. 
DI*01 was observed in 6 populations (Pashto, Tajik, Turkmen, Balochi, Hazara and Sindhi) between 
1% and 3%. CO*02 was spotted in the Hazara (1%), the Turkmen (1%) and the Burusho (2%). The 
frequency of the FY*02N.01 allele was low in Afghan samples (range, 1 to 5%) but interestingly 
reached 12% in the Baloshi and 18% in the Makrani from Pakistan. After cross-validation with the 
raw data and using the EM algorithm supplied in the GENE[RATE] package (Nunes 2006), we could 
ensure that they all FY silent mutations were associated with the Fyb-specific polymorphism. Lastly, 
JK*01 and YT*01 ranged respectively between 48% (Burusho) and 73% (Kalash), and 84% (Pathan) 
and 100% (Brahui).  
 
DISCUSSION 
The present study provides serologic frequencies in order to ensure safe blood transfusion in 
Afghanistan. We especially performed two multiplex molecular analyses which amplified 
simultaneously alleles coding for RBC antigens either major for transfusion and anthropological 
purposes in the same Afghan populations enriched with DNA samples from Pakistan. These molecular 
arrays turned to be preferentially employed because they were low-cost, fast, and avoided the clinical 
shortcomings of the hemagglutination-based assays (Di Cristofaro et al. 2010). Importantly, no 
discordance was observed between the phenotype inferred from the SNaPshot genotyping and the 
control samples, so we assume that the method herein presented covered accurately the DNA regions 
of interest. 
We then compared the frequencies obtained with that of the main geographical areas of 
interest (Table 3), and the following patterns were outstanding. The mean frequency of the ABO*B.01 
allele was higher in Afghan populations than in Sub-Saharan (13%) and Eurasian (7-20%) 
populations. Similar frequencies have been reported in South and Central Asia (25-35%) (Mourant et 
al. 1958; Abawi et al. 2001; Keramati et al. 2011). In addition, the D-C-E-c+e+ phenotype and the 
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KEL*01.1, FY*01, DI*01 and YT*02 allele frequencies in the Afghan groups were intermediate 
between those observed in Western Europeans and East Asians in agreement with earlier reports 
describing the clinal frequencies of the D-C-E-c+e+ phenotype and K, Fyb, Dia and Ytb antigens across 
Eurasia (Cavalli-Sforza et al. 1994; Reid et al. 2012).  
Previous analysis of gene flow patterns in Afghanistan that is located at the crossroad between 
West and East Asia have documented waves of population migration resulting in substantial gene 
admixture (Quintana-Murci et al. 2004). In this view, we also detected in addition to the DI*01 allele, 
classically related to Mongols expansion, the LW*07, and FY*02N.01 alleles unusually encountered in 
Central Asian but in Northern European and Sub-Saharan populations (M'Baya et al. 2010; Howes et 
al. 2011; Reid et al. 2012). Another puzzling finding with respect to blood group alleles involves 
IN*01 coding for Ina whose current geographical distribution is split into two cores: Middle Eastern 
(Cavalli-Sforza et al. 1994; Reid et al. 2012) and South Asian (Badakere et al. 1974) populations. 
Curiously the geographical distribution of IN*01 matches that of the Elamo-Dravidian language 
family, a past linguistic cluster linking modern Dravidian languages spoken in southern India to the 
extinct Elamite language formerly spoken in southwestern Iran. This suggests that diffusion of IN*01 
into India took place about 4,500 years ago by Elamo-Dravidian populations (Cavalli-Sforza et al. 
1994). The presence of IN*01 in Afghanistan and in northern Pakistan supports the possibility of an 
ancient settlement of Elamo-Dravidian populations in Central Asia and adds to our understanding of 
the current distribution area of the Ina antigen.  
Furthermore, Central and South Asia are known to be the original reservoir of cholera (Sack et 
al. 2004) and plague bacteria (Achtman et al. 2004), and the southern coast of Pakistan has been 
defined as a malaria transmission area (WHO 2011). Since RBC antigens can act as fixation sites for 
infectious organisms (Telesmanich et al. 2008; Howes et al. 2011), it is plausible that directive 
selection played a role in the evolution of the different human antigenic profiles, notably in our region 
of study. Previously attempts suggested that individuals who can make anti-H were likely to be more 
resistant to the plague and cholera (Garraty 2005; Harris et al. 2005; Telesmanich et al. 2008). The 
high frequency of the B phenotype in our samples does not contradict this plausible hypothesis. Also, 
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the higher presence in the Makrani of the FY silent allele could offer a selective advantage against 
Plasmodium vivax. Nonetheless, we detected in the Makrani samples 14% of the Fya-/Jkb-/S- 
phenotype; a component found in 31.5% in Africans as opposed to only 4.5% of Europeans (Noizat-
Pirenne 2003), and the Makrani were further documented by 39.4% of mitochondrial haplotypes of 
African origin (Quintana-Murci et al. 2004). In this regard, our data are consistent with the notion of 
overlapping blood group allele frequencies between Western Eurasia and East Asia, gene exchanges, 
and probably positive selection.  
For the last two decades, there have been several blood group surveys in the urban populations 
of Afghanistan which have mainly highlighted major failures in the blood handling coupled with a 
worrying microbiological situation (Todd et al. 2007; Ayyoubi et al. 2010; Khan and Attaullah 2011). 
Compatibility screening in Afghanistan is currently restricted to the ABO, RHD, and K key antigens 
(Dupire et al. 1999; Abawi et al. 2001). In emergency situations, e.g. after bombing, it is limited to 
ABO compatibility only without detection of HIV, HBV, or HCV viral markers. These practices must 
be considered as extremely hazardous, noticeably because of the vaccination rate against hepatitis in 
the country, a high level of drug use in urban areas, and several high-risk cultural practices including 
tattooing (Todd et al. 2007; Khan and Attaullah 2011). Fewer than half of emerging countries perform 
pre-donation medical interviewing to identify risk factors and post-collection testing to detect viral 
markers (Dupire et al. 1999). To further enhance safety, the commercially ELISA combo test should 
be used in order to prevent HIV and HCV contamination by blood products.  
The present study provided a wide array of RBC antigens in Afghan donors and Pakistani 
populations in the ethnographic and blood transfusion contexts of Afghanistan. These study’s findings, 
which were forwarded to the NBC in Kabul, emphasized how crucial the estimation of biological 
diversity is in a panel of Afghan donors in defining standards for safe blood collection and release in 
the area.  
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Legends 
 
Table 1. Primer and probe sequences used for blood group amplification in the 10-pair multiplex PCR 
(Bruce et al. 1994; Hermand et al. 1995; Lee et al. 1995; Tournamille et al. 1995a; 
Tournamille et al. 1995b; Telen et al. 1996; Gubin et al. 2000; Rios et al. 2002).  
 
Table 2. Occurrence and frequencies of the ABO, Rh and Kell phenotypes in five Afghan populations 
 
Table 3. Allele and haplotype frequencies of the ABO, Rh and Kell blood group systems in five 
Afghan populations compared to published data. (Cavalli-Sforza et al. 1994; Nanu and 
Thapliyal 1997; Dupire et al. 1999; Asadov et al. 2003; Periyavan et al. 2010; Thakral et al. 
2010; Keramati et al. 2011; Radzhabov et al. 2011; Reid et al. 2012). 
 
Table 4. Frequencies of 15 biallelic polymorphisms in five Afghan and eight Pakistani populations. 
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Table 1. Primer and probe sequences used for blood group amplification in the 10-pair multiplex PCR (Bruce et al. 1994; Hermand et al. 1995; Lee et al. 
1995; Tournamille et al. 1995a; Tournamille et al. 1995b; Telen et al. 1996; Gubin et al. 2000; Rios et al. 2002).  
 
System Allele 
Amino-acid 
change & SNP 
Location Forward (5' to 3') Extension primer (Forward/Reverse)
a
 Reverse (5' to 3') 
Amplicon & 
primer size (bp) 
Conc. 
(µM) 
KEL KEL*02.06 Pro597Leu Exon 17 CACCCACATCCTCACCTAGG  TGAGCTTCCTGGAGGGCATG 126 0.13 
1790C>T  (F) AGTACTGCCTGGGGGCTGCC  20 0.1 
FY FY*01/FY*02 Gly42Asp Exon 2 TCCCCCTCAACTGAGAACTC  AAGGCTGAGCCATACCAGAC 392 0.63 
125G>A (F) 5T-CTTCCCAGATGGAGACTATG 25 1 
FY*02M.01 Arg89Cys    
265C>T (F) 10T-TGCTTTTCAGACCTCTCTTC 30 1 
FY*02N.01  Promoter CCAAGGCCAGTGACCCCCATA  CATGGCACCGTTTGGTTCAG 190 0.13 
-67T>C  (F) 15T-TCATTAGTCCTTGGCTCTTA  35 0.3 
DI DI*01/DI*02 Pro854Leu Exon 19 GGTGGTAGAGGGTGCTGG  GACACAGCAGGCCAGAAC 364 0.63 
2561C>T  (R) 20T-AGGGCAGGGCCAGGGAGGCC  40 1.2 
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Table 1. continued 
 
System Allele Amino-acid 
change & SNP 
Location Forward (5' to 3') Extension primer (Forward/Reverse)a Reverse (5' to 3') Amplicon & 
primer size (bp) 
Conc. 
(µM) 
DO DO*01/DO*02 Asn265Asp Exon 2 ACACAGGGGCCACCATTCGATT  TGTGCTCAGGTTCCCAGTTG 242 0.63 
793A>G  (R) 35T-TGACCTCAACTGCAACCAGT  55 0.05 
DO*02.-04 Gly108Val  GATCAGTACCAAGGCTGTAGC  GAATGAACATTGCTGTTCAATG 212 0.81 
323G>T (R) 25T-TGTTCTGGGGTAGAACTTTT 45 0.4 
DO*01.-05 Thr117Ile   0.81 
350C>T (R) 30T-AAATAGCCACAGCGTGTGTG 50 0.4 
LW LW*05/LW*07 Gln100Arg Exon 1 GGGAAGTCAGTGCAGCTCAA  GCAGGTCACGAGGCAGTG 168 0.13 
299A>G  (F) 40T-GCCGGGTTGGGTGTCTTACC  60 0.05 
IN IN*01/IN*02 Pro46Arg Exon 2 GCCGCTTTGCAGGTGTATTC  CCAGTTGTCATACAGGTTGC 317 0.63 
137C>G  (F) 45T-TGGTCGCTACAGCATCTCTC  65 0.2 
a
 Bold characters refer to the 5' poly-thymidine tail 
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Table 2. Occurrence and frequencies of the ABO, Rh and Kell phenotypes in five Afghan populations  
 
 
 
Hazara 
N=77 
Pashto 
N=81 
Tajik 
N=140 
Turkmen 
N=70 
Uzbek 
N=121 
ABO A 24 (0.31) 21 (0.26) 42 (0.3) 16 (0.23) 35 (0.29) 
 AB 3 (0.04) 12 (0.15) 18 (0.13) 10 (0.14) 16 (0.13) 
 B 25 (0.32) 20 (0.25) 44 (0.31) 20 (0.29) 37 (0.31) 
 O 25 (0.32) 28 (0.35) 36 (0.26) 24 (0.34) 33 (0.27) 
Rh D-C+E-c+e+ 2 (0.03) - - 1 (0.01) - 
 D-C-E-c+e+ 10 (0.13) 5 (0.06) 8 (0.06) 6 (0.09) 9 (0.07) 
 D-C-E+c+e+ - - 1 (0.01) - - 
 D+C+E-c+e+ 17 (0.22) 23 (0.28) 46 (0.33) 16 (0.23) 31 (0.26) 
 D+C+E+c+e+ 15 (0.19) 14 (0.17) 23 (0.16) 12 (0.17) 23 (0.19) 
 D+C+E-c-e+ 28 (0.36) 30 (0.37) 44 (0.31) 25 (0.36) 44 (0.36) 
 D+C-E+c+e+ 5 (0.06) 9 (0.11) 18 (0.13) 10 (0.14) 14 (0.12) 
Kell K-k+ 75 (0.97) 77 (0.95) 139 (0.99) 69 (0.99) 114 (0.94) 
 K+k- 2 (0.03) 4 (0.05) 1 (0.01) 1 (0.01) 7 (0.06) 
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Table 3. Allele and haplotype frequencies of the ABO, Rh and Kell blood group systems in five Afghan populations compared to published data. (Cavalli-
Sforza et al. 1994; Nanu and Thapliyal 1997; Dupire et al. 1999; Asadov et al. 2003; Periyavan et al. 2010; Thakral et al. 2010; Keramati et al. 2011; 
Radzhabov et al. 2011; Reid et al. 2012). 
 
 
Hazara Pashto Tajik Turkmen Uzbek Western Europe Sub-Sahara West Asia South Asia East Asia 
ABO  
          ABO*AO1 0.20 0.23 0.24 0.20 0.24 0.27 0.17 0.24 0.18 0.20 
ABO*B01 0.21 0.22 0.25 0.24 0.25 0.07 0.13 0.19 0.23 0.20 
ABO*O.01.01 0.60 0.56 0.50 0.56 0.51 0.66 0.70 0.56 0.58 0.59 
RH  
          DCe 0.51 0.53 0.54 0.52 0.54 0.42 0.17 0.44 0.72 0.69 
DcE 0.16 0.18 0.13 0.17 0.19 0.14 0.11 0.13 0.09 0.20 
Dce - 0.04 0.03 - 0.03 0.04 0.44 0.09 0.04 0.05 
DCE - 0.01 0.02 - - - - 0.02 0.03 0.01 
dCe 0.05 - - 0.03 - 0.02 0.02 0.01 0.03 0.01 
dcE - - 0.01 - - 0.01 - 0.01 - - 
dce 0.29 0.24 0.26 0.28 0.25 0.37 0.26 0.28 0.10 0.03 
dCE - - - - - - - 0.01 - - 
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Table 3. continued 
 
 
Hazara Pashto Tajik Turkmen Uzbek Western Europe Sub-Sahara West Asia South Asia East Asia 
Kell 
          KEL*01.1 0.97 0.95 0.99 0.99 0.94 0.91 0.98 0.98 0.96 0.99 
KEL*02 0.03 0.05 0.01 0.01 0.06 0.09 0.02 0.02 0.04 0.01 
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Table 4. Frequencies of 15 biallelic polymorphisms in five Afghan and eight Pakistani populations. 
 
System Allele 
Afghanistan   Pakistan  
Hazara 
n=62 
Pashto 
n=71 
Tajik 
n=123 
Turkmen 
n=67 
Uzbek 
n=108 
  Balochi 
n=21 
Brahui 
n=19 
Burusho 
n=24 
Hazara 
n=20 
Kalash 
n=24 
Makrani 
n=17 
Pathan 
n=22 
Sindhi 
n=21 
MNS GYPB*03 0.23 0.36 0.30 0.22 0.30  0.40 0.45 0.21 0.28 0.19 0.35 0.39 0.38 
 
GYPB*04 0.77 0.64 0.70 0.78 0.70  0.60 0.55 0.79 0.73 0.81 0.65 0.61 0.62 
KEL KEL*01.1 0.02 0.04 0.00 0.01 0.04  0.00 0.03 0.02 0.03 0.00 0.00 0.00 0.00 
 
KEL*02 0.98 0.96 1.00 0.99 0.96  1.00 0.97 0.98 0.98 1.00 1.00 1.00 1.00 
 
KEL*02.06 0.00 0.00 0.01 0.00 0.00  0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
FY FY*01 0.64 0.52 0.54 0.47 0.62  0.48 0.58 0.58 0.73 0.54 0.47 0.59 0.69 
 
FY*02 0.36 0.48 0.46 0.53 0.38  0.52 0.42 0.42 0.28 0.46 0.53 0.41 0.31 
FY*02M.01 0.00 0.03 0.01 0.01 0.01  0.00 0.00 0.00 0.00 0.06 0.00 0.00 0.00 
 FY*02N.01 0.01 0.00 0.01 0.03 0.00  0.12 0.03 0.00 0.00 0.00 0.18 0.00 0.00 
DI DI*01 0.00 0.01 0.01 0.03 0.00  0.02 0.00 0.00 0.03 0.00 0.00 0.00 0.02 
 
DI*02 1.00 0.99 0.99 0.97 1.00  0.98 1.00 1.00 0.98 1.00 1.00 1.00 0.98 
DO DO*01 0.39 0.37 0.37 0.38 0.36 
 
0.29 0.45 0.31 0.28 0.42 0.62 0.45 0.29 
 
DO*02 0.61 0.63 0.63 0.62 0.64 
 
0.71 0.55 0.69 0.73 0.58 0.38 0.55 0.71 
 
DO*02.-04 1.00 1.00 1.00 1.00 1.00 
 
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 
DO*01.-05 1.00 1.00 1.00 1.00 1.00 
 
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
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Table 4. Continued. 
 
System Allele 
Afghanistan   Pakistan  
Hazara 
n=62 
Pashto 
n=71 
Tajik 
n=123 
Turkmen 
n=67 
Uzbek 
n=108 
  Balochi 
n=21 
Brahui 
n=19 
Burusho 
n=24 
Hazara 
n=20 
Kalash 
n=24 
Makrani 
n=17 
Pathan 
n=22 
Sindhi 
n=21 
IN IN*01 0.00 0.00 0.01 0.00 0.00 
 
0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 
 
IN*02 1.00 1.00 0.99 1.00 1.00 
 
1.00 1.00 0.98 1.00 1.00 1.00 1.00 1.00 
LW LW*05 1.00 1.00 1.00 0.99 1.00 
 
1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 
 
LW*07 0.00 0.00 0.00 0.01 0.00 
 
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
CO CO*01.01 0.99 1.00 1.00 0.99 1.00 1.00 1.00 0.98 1.00 1.00 1.00 1.00 1.00 
 CO*02 0.01 0.00 0.00 0.01 0.00  0.00 0.00 0.02 0.00 0.00 0.00 0.00 0.00 
JK  JK*01 0.52 0.51 0.51 0.60 0.51 
 
0.55 0.50 0.48 0.60 0.73 0.71 0.50 0.50 
 
JK*02 0.48 0.49 0.49 0.40 0.49 
 
0.45 0.50 0.52 0.40 0.27 0.29 0.50 0.50 
YT  YT*01 0.90 0.91 0.90 0.88 0.94 
 
0.90 1.00 0.92 0.90 0.83 0.91 0.84 0.86 
  YT*02 0.10 0.09 0.10 0.12 0.06  0.10 0.00 0.08 0.10 0.17 0.09 0.16 0.14 
 
